vs
Esperion Therapeutics, Inc.（ESPR）与KEY TRONIC CORP（KTCC）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是KEY TRONIC CORP的1.7倍（$168.4M vs $96.3M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -15.4%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -17.8%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Key Tronic成立于1969年，最初主营键盘、鼠标等输入设备，目前专注于印刷电路板组装与成品整机组装业务，是美国规模前十的电子制造服务代工厂，可为各类消费家电及电子产品提供完整的产品设计与组装代工服务。
ESPR vs KTCC — 直观对比
营收规模更大
ESPR
是对方的1.7倍
$96.3M
营收增速更快
ESPR
高出159.1%
-15.4%
两年增速更快
ESPR
近两年复合增速
-17.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $96.3M |
| 净利润 | — | $-8.6M |
| 毛利率 | — | 0.6% |
| 营业利润率 | 50.6% | -10.7% |
| 净利率 | — | -8.9% |
| 营收同比 | 143.7% | -15.4% |
| 净利润同比 | — | -74.4% |
| 每股收益（稀释后） | $0.32 | $-0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRKTCC
| Q4 25 | $168.4M | $96.3M | ||
| Q3 25 | $87.3M | $98.8M | ||
| Q2 25 | $82.4M | $110.5M | ||
| Q1 25 | $65.0M | $112.0M | ||
| Q4 24 | $69.1M | $113.9M | ||
| Q3 24 | $51.6M | $131.6M | ||
| Q2 24 | $73.8M | $126.6M | ||
| Q1 24 | $137.7M | $142.4M |
净利润ESPRKTCC
| Q4 25 | — | $-8.6M | ||
| Q3 25 | $-31.3M | $-2.3M | ||
| Q2 25 | $-12.7M | $-3.9M | ||
| Q1 25 | $-40.5M | $-604.0K | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $-29.5M | $1.1M | ||
| Q2 24 | $-61.9M | $-2.0M | ||
| Q1 24 | $61.0M | $-2.2M |
毛利率ESPRKTCC
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 8.4% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | 7.2% | ||
| Q1 24 | — | 5.7% |
营业利润率ESPRKTCC
| Q4 25 | 50.6% | -10.7% | ||
| Q3 25 | -11.4% | -0.6% | ||
| Q2 25 | 8.6% | -2.1% | ||
| Q1 25 | -34.0% | -0.4% | ||
| Q4 24 | -6.4% | -1.0% | ||
| Q3 24 | -31.0% | 3.4% | ||
| Q2 24 | 3.5% | 0.1% | ||
| Q1 24 | 52.5% | -0.4% |
净利率ESPRKTCC
| Q4 25 | — | -8.9% | ||
| Q3 25 | -35.9% | -2.3% | ||
| Q2 25 | -15.4% | -3.6% | ||
| Q1 25 | -62.2% | -0.5% | ||
| Q4 24 | — | -4.3% | ||
| Q3 24 | -57.2% | 0.9% | ||
| Q2 24 | -83.9% | -1.6% | ||
| Q1 24 | 44.3% | -1.6% |
每股收益（稀释后）ESPRKTCC
| Q4 25 | $0.32 | $-0.79 | ||
| Q3 25 | $-0.16 | $-0.21 | ||
| Q2 25 | $-0.06 | $-0.35 | ||
| Q1 25 | $-0.21 | $-0.06 | ||
| Q4 24 | $-0.14 | $-0.46 | ||
| Q3 24 | $-0.15 | $0.10 | ||
| Q2 24 | $-0.33 | $-0.18 | ||
| Q1 24 | $0.34 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $788.0K |
| 总债务越低越好 | — | $97.7M |
| 股东权益账面价值 | $-302.0M | $106.2M |
| 总资产 | $465.9M | $325.3M |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资ESPRKTCC
| Q4 25 | $167.9M | $788.0K | ||
| Q3 25 | $92.4M | $1.1M | ||
| Q2 25 | $86.1M | $1.4M | ||
| Q1 25 | $114.6M | $2.5M | ||
| Q4 24 | $144.8M | $4.2M | ||
| Q3 24 | $144.7M | $6.6M | ||
| Q2 24 | $189.3M | $4.8M | ||
| Q1 24 | $226.6M | $5.3M |
总债务ESPRKTCC
| Q4 25 | — | $97.7M | ||
| Q3 25 | — | $100.8M | ||
| Q2 25 | — | $105.2M | ||
| Q1 25 | — | $113.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $112.7M | ||
| Q2 24 | — | $119.5M | ||
| Q1 24 | — | $125.3M |
股东权益ESPRKTCC
| Q4 25 | $-302.0M | $106.2M | ||
| Q3 25 | $-451.4M | $114.8M | ||
| Q2 25 | $-433.5M | $117.1M | ||
| Q1 25 | $-426.2M | $119.6M | ||
| Q4 24 | $-388.7M | $119.5M | ||
| Q3 24 | $-370.2M | $124.3M | ||
| Q2 24 | $-344.2M | $124.0M | ||
| Q1 24 | $-294.3M | $130.1M |
总资产ESPRKTCC
| Q4 25 | $465.9M | $325.3M | ||
| Q3 25 | $364.0M | $324.6M | ||
| Q2 25 | $347.1M | $315.9M | ||
| Q1 25 | $324.0M | $328.6M | ||
| Q4 24 | $343.8M | $327.8M | ||
| Q3 24 | $314.1M | $355.9M | ||
| Q2 24 | $352.3M | $355.3M | ||
| Q1 24 | $373.1M | $370.1M |
负债/权益比ESPRKTCC
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.88× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 0.93× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.96× | ||
| Q1 24 | — | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $6.4M |
| 自由现金流经营现金流 - 资本支出 | — | $3.1M |
| 自由现金流率自由现金流/营收 | — | 3.2% |
| 资本支出强度资本支出/营收 | 0.0% | 3.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $11.6M |
8季度趋势，按日历期对齐
经营现金流ESPRKTCC
| Q4 25 | $45.2M | $6.4M | ||
| Q3 25 | $-4.3M | $7.6M | ||
| Q2 25 | $-31.4M | $8.8M | ||
| Q1 25 | $-22.6M | $-1.4M | ||
| Q4 24 | $-35.0M | $1.6M | ||
| Q3 24 | $-35.3M | $9.9M | ||
| Q2 24 | $-7.2M | $7.7M | ||
| Q1 24 | $53.8M | $-3.0M |
自由现金流ESPRKTCC
| Q4 25 | — | $3.1M | ||
| Q3 25 | — | $4.4M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-35.5M | $9.6M | ||
| Q2 24 | $-7.3M | $7.1M | ||
| Q1 24 | $53.8M | $-3.8M |
自由现金流率ESPRKTCC
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 7.0% | ||
| Q1 25 | — | -3.2% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | -68.7% | 7.3% | ||
| Q2 24 | -9.9% | 5.6% | ||
| Q1 24 | 39.0% | -2.7% |
资本支出强度ESPRKTCC
| Q4 25 | 0.0% | 3.4% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.0% | 2.0% | ||
| Q4 24 | 0.0% | 0.4% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ESPRKTCC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.85× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
KTCC
| Transferred Over Time | $91.3M | 95% |
| Transferred At Point In Time | $5.0M | 5% |
